NNNN

Handel nachbörslich: 51.70 0.03 +0.06%

Anbio Biotechnology (NNNN)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Anbio Biotechnology Stock (NNNN) Company Profile

Anbio Biotechnology

Healthcare (1159)

Nächster Verdiensttermin

Neueste SEC-Einreichungen

NNNN's Discussions on Twitter

Vergleichen Sie NNNN mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
NNNN Anbio Biotechnology	51.67	2.23B	0	0	0	0.00
ISRG Intuitive Surgical Inc	481.28	172.16B	9.15B	2.63B	1.99B	7.17
BDX Becton Dickinson Co	195.00	56.16B	21.39B	1.61B	2.55B	5.56
ALC Alcon Inc	88.13	43.38B	9.93B	1.12B	1.43B	2.26
RMD Resmed Inc	286.12	41.71B	5.15B	1.40B	1.65B	9.51
WST West Pharmaceutical Services Inc	243.09	17.70B	2.96B	487.70M	344.00M	6.68

Anbio Biotechnology Aktie (NNNN) Neueste Nachrichten

Finanzdaten der Anbio Biotechnology-Aktie (NNNN)

Es liegen keine Finanzdaten für Anbio Biotechnology (NNNN) vor. Überprüfen Sie andere Aktien für weitere Informationen.

Anbio Biotechnology (NNNN)

Anbio Biotechnology Stock (NNNN) Company Profile

Vergleichen Sie NNNN mit anderen Aktien

Anbio Biotechnology Aktie (NNNN) Neueste Nachrichten

The Unlocking of Voting Control in Anbio Biotechnology: A Post-Lock-Up Opportunity in a Dual-Class IPO - AInvest

Anbio Biotechnology's Post-Lock-Up Investment Implications: Unlocking Shareholder Value and Market Dynamics - AInvest

Certain Class B Ordinary Shares of Anbio Biotechnology are subject to a Lock-Up Agreement Ending on 18-AUG-2025. - MarketScreener

Will Aquestive Therapeutics Inc. price bounce be sustainablePortfolio Growth Summary & High Accuracy Swing Entry Alerts - Newser

Can MNTK expand its profit marginsMarket Trend Review & AI Forecasted Stock Moves - thegnnews.com

CompanyInsider Selling & Reliable Breakout Stock Forecasts - Newser

Zhengye Skyrocketed 33.84%—What’s Fueling This Biotech Breakout? - AInvest

Will The Southern Company Preferred Security benefit from macro trendsMulti-Year Signal Summary and Entry Timing - Newser

enCore Energy Corp. stock prediction for this weekFree ROI Boosting Trade Opportunity Calendar - Newser

Anbio Biotechnology Responds to Global Outbreaks with Chikungunya Rapid Test and New 15-Minute Ultra-Fast PCR System - digitalmore.co

Anbio Biotechnology's Strategic Expansion into Point-of-Care Diagnostics: A High-Growth Opportunity in Global Infectious Disease Management - AInvest

Breakthrough: Anbio's 15-Minute PCR System and Chikungunya Test Transform Disease Detection - Stock Titan

Anbio Biotechnology Responds to Global Outbreaks with Chikungunya Rapid Test and New 15-Minute Ultra-Fast PCR System - GlobeNewswire Inc.

Why Coherus BioSciences Inc. stock attracts strong analyst attentionSummary of Trade Cycles in 5-Year Range - Newser

Full technical analysis of AFSC stockEarnings Based Stock Performance Forecast - Newser

Anbio Biotechnology (NNNN) Surges 13% in Dramatic Intraday Rally – What’s Fueling the Momentum? - AInvest

7 healthtech scaleups to watch in Europe & UK in 2025 - Tech Funding News

Is FORR stock bottoming outCapital Growth Plan for New Investors - Newser

Will Intuitive Machines Inc. stock recover after recent dropIntraday Movement Recap and Chart Summary - Newser

IRBT stock daily chart insightsDownside Control Plan With Support Analysis - Newser

Why UGRO stock attracts strong analyst attentionFree Early Entry Tips With Low Risk Zone - Newser

BAC.PRCC stock prediction for this weekFree Smart Money Tracking Signal Generator - Newser

Price momentum metrics for Iterum Therapeutics plc explainedEarly Entry Ideas with Momentum Potential - Newser

What Anbio Biotechnology's (NASDAQ:NNNN) ROE Can Tell Us - simplywall.st

Is a relief rally coming for BriaCell Therapeutics Corp. Equity Warrant holdersFree Stock Selection With High Accuracy - Newser

How to escape a deep drawdown in HTOOFree Pattern Breakout Entry Stock Forecast - Newser

Has ESLT formed a bullish divergenceFree Short Term Buy List With Stop Protection - Newser

Why CARGO Therapeutics Inc. stock attracts strong analyst attentionAI Trading Forecast Based on Big Data - Newser

What momentum shifts mean for C.PRGCSwing Reversal Forecast Based on Patterns - Newser

Is Enigmatig Limited stock bottoming outFree Trade Timing Strategy With Technical Data - Newser

How many analysts rate Anbio Biotechnology as a “Buy”Swing Trade Report For Consistent Profits - Jammu Links News

Risk vs reward if holding onto Anbio BiotechnologyEarnings Report Summary with Market Impact - Newser

Sentiment analysis tools applied to DHT Holdings Inc.Free Accurate Technical Trend Reversal Picks - Newser

What makes Anbio Biotechnology stock price move sharplyFree Fundamental Growth Stock Analysis - Newser

Using R and stats models for Otis Worldwide Corporation forecastingAlgorithmic Forecast for Swing Trading Picks - Newser

What catalysts could drive Anbio Biotechnology stock higher in 2025Top Growth Data Feed From AI Tools - Jammu Links News

What is Anbio Biotechnology company’s growth strategyPost Market Opportunities With High Returns - Jammu Links News

Applying sector rotation models to Signing Day Sports Inc.Free Access to Smart Investment Tips - Newser

Why Anbio Biotechnology stock attracts strong analyst attentionMomentum Screener with Buy and Sell Areas - Newser

Institutional scanner results for Anbio BiotechnologyDaily Exit and Entry Price Prediction - Newser

Alnylam Pharmaceuticals Skyrocketed 16.26%—Can This Biotech Breakout Sustain Momentum? - AInvest

Anbio Biotechnology's 15min chart sees KDJ Golden Cross and Bullish Marubozu - AInvest

Why Churchill Capital Corp IX stock attracts strong analyst attentionChart Confirmation Setup with ROI Signals - Newser

Using fundamentals and technicals on CDNSFree Daily Picks With Predictable Performance - Newser

Anbio Biotechnology Plunges 8.67%, What Storm Is Brewing in the Diagnostics Sector? - AInvest

Inmune Bio shares fall 2.53% premarket after announcing a video detailing MINDFuL trial findings. - AInvest

Is Anbio Biotechnology Stock a Smart Buy in 2025 Investment Analysis InsideYield Curve Outlook and Long-Term Implication Summary - Newser

Anbio Biotechnology Trading Near Value Zone — Recovery AheadPattern Detection for Entry Confirmation Enabled - metal.it

Technical signs of recovery in Anbio BiotechnologyAI Powered Buy Point Forecast Planner - Newser

How high can ICMB stock price go in 2025Free Early Breakout Entry Point Notifications - Newser

Comparing Anbio Biotechnology in custom built stock radarsConservative Investment Setup and Risk Analysis - Newser

Finanzdaten der Anbio Biotechnology-Aktie (NNNN)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie NNNN